Literature DB >> 938021

Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.

R N Jones, P C Fuchs.   

Abstract

Antimicrobial susceptibility to cefamandole versus cephalothin and cefazolin versus cephalothin was compared by the broth microdilution method against 3,000 and 5,895 clinical bacterial isolates, respectively. Cefamandole and, to a lesser degree, cefazolin showed greater activity than cephalothin against Enterobacteriaceae, but the three drugs were comparable against gram-positive cocci.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938021      PMCID: PMC429673          DOI: 10.1128/AAC.9.6.1066

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  In vitro studies with cefazolin.

Authors:  M Motley; S Shadomy
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

2.  Comparison of cefazolin, a new cephalosporin antibiotic, with cephalothin.

Authors:  J P Phair; J Carleton; J S Tan
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

3.  In vitro activity of cefazolin against recent clinical bacterial isolates.

Authors:  L D Sabath; C Wilcox; C Garner; M Finland
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

4.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

5.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

6.  Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.

Authors:  K Ries; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

7.  Evaluation of cefazolin, a new cephalosporin antibiotic.

Authors:  L B Reller; W W Karney; H N Beaty; K K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

  7 in total
  10 in total

Review 1.  Bacterial antibiotic resistance before and after clinical application in the United States.

Authors:  A L Barry; R N Jones
Journal:  Bull N Y Acad Med       Date:  1987-04

2.  Therapy of serious infections with cefamandole.

Authors:  M F Parry; M J Goldberger; H C Neu
Journal:  Infection       Date:  1978       Impact factor: 3.553

3.  Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).

Authors:  C Krasemann; H Werner; G Hildenbrand; M Benning; U Brandt; J Ungerechts
Journal:  Infection       Date:  1980       Impact factor: 3.553

4.  Pharmacokinetics of cefamandole using a HPLC assay.

Authors:  N S Aziz; J G Gambertoglio; E T Lin; H Grausz; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.

Authors:  P C de Girolami; L A Maher; M T Booth; D M St George
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

6.  Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.

Authors:  R N Jones; P C Fuchs; A L Barry; T L Gavan; H M Sommers; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

7.  Cefamandole therapy in anaerobic infections.

Authors:  R N Greenberg; M C Scalcini; C V Sanders; A C Lewis
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

8.  LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas.

Authors:  D J Flournoy; F A Perryman
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

9.  In vitro activity of LY127935.

Authors:  M Barza; F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

Review 10.  The cephalosporins: activity and clinical use.

Authors:  A J Weinstein
Journal:  Drugs       Date:  1980-08       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.